Abivax SA (ABVX)
121.83
-0.64
(-0.52%)
USD |
NASDAQ |
Apr 17, 11:47
Abivax Research and Development Expense (Quarterly) : 51.68M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| AstraZeneca PLC | 3.725B |
| Eli Lilly & Co. | 3.802B |
| DBV Technologies SA | 30.04M |
| Insmed, Inc. | 254.91M |
| Nicox SA | -- |